Skip to main content
Dryad

Data from: Transplantation of exogenous mitochondria mitigates myocardial dysfunction after cardiac arrest

Data files

Apr 17, 2025 version files 39.75 MB

Click names to download individual files

Abstract

The incidence of post-cardiac arrest myocardial dysfunction (PAMD) is high, and there is currently no effective treatment available. This study aims to investigate the protective effects of exogenous mitochondrial transplantation. Exogenous mitochondrial transplantation can enhance myocardial function and improve the survival rate. Mechanistic studies suggest that mitochondrial transplantation can limit impairment in mitochondrial morphology, augment the activity of mitochondrial complexes II and IV, and raise ATP level. As well, mitochondrial therapy ameliorated oxidative stress imbalance, reduced myocardial injury, and thus improved PAMD after cardiopulmonary resuscitation (CPR).

Our study aims to investigate the protective effects of exogenous mitochondrial transplantation on the myocardium following cardiac arrest. We utilize a rat model of asphyxiation-induced cardiac arrest. Once the model is established, the rats are humanely euthanized for sample collection or survival analysis.